Dr. Scott E. Delacroix, MD

Dr. Delacroix practices at Touro Infirmary in New Orleans, Louisiana, part of LCMC Health.

Dr. Delacroix's NPI, 1962625798, was assigned on April 10, 2007. Dr. Delacroix graduated from LSU Health Sciences Center New Orleans - School of Medicine in 2004. Dr. Delacroix holds Louisiana license 200676.

Dr. Delacroix's primary practice is Touro Infirmary, at 1401 Foucher Street, New Orleans, LA 70115 in Orleans Parish. The practice phone is (504) 897-8247.

Dr. Delacroix's primary practice is Touro Infirmary in New Orleans, Louisiana, part of LCMC Health. Dr. Delacroix is also affiliated with East Jefferson General Hospital. The medical group on file is LSU Healthcare Network. Dmand AI also links Dr. Delacroix to 3 more hospitals, 1 clinical lab, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Delacroix practices, 7 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Delacroix's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Delacroix is board certified in urology by the American Board of Urology. Dmand AI has Dr. Delacroix's licenses on file in 4 states: Louisiana, Mississippi, Alabama and Texas.

Dmand AI lists bladder removal, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney removal surgery, kidney stones, prostate cancer and prostate inflammation or infection among the conditions Dr. Delacroix treats.

CMS data shows 6,585 Medicare services from Dr. Delacroix across 11 procedure codes in 2024, for 274 Medicare patients. Medicare paid $82,071 for them.

CMS counts 274 Medicare patients who saw Dr. Delacroix in 2024. The largest group is 65 to 74, with 148 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.28, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Delacroix's median patient age at 71, with 10% women.

In 2024, Dr. Delacroix wrote 1,150 Medicare Part D claims for 179 patients. 91% of them were for generic drugs. CMS names the drug for 1,041 of them, across 9 drugs with 11 or more claims each, at $1,137,877 in total drug cost. In 2023, CMS named 1,142 claims across 13 drugs.

Dr. Delacroix accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Delacroix as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 44 papers to Dr. Delacroix, published from 2010 to 2025. 2015 was the busiest year, with 5. The most frequent topics are Carcinoma, Renal Cell, Kidney Neoplasms and Prostatic Neoplasms. Dr. Delacroix has published most often in Clin Colon Rectal Surg. Dr. Delacroix's most frequent co-authors are Brian Francis Chapin, MD, Brian Christopher Baumann, MD and Peter C. Black, MD.

Dmand AI links Dr. Delacroix to 13 clinical trials, 6 of them phase 2 studies. 12 are still active or recruiting. Conditions studied include Prostatic Neoplasms, Prostatic Diseases and Urinary Bladder Neoplasms. National Cancer Institute (NCI) sponsors the most, 6.

CMS Open Payments shows 118 general payments to Dr. Delacroix from 27 drug and device companies from 2016 to 2019. Food and beverage make up the largest share, 93% of the total. Pfizer Inc. paid the most, $473.

Dmand AI lists 1 award for Dr. Delacroix, most recently CMS Stage 1 EHR in 2013.

Dr. Delacroix graduated from LSU Health Sciences Center New Orleans - School of Medicine in 2004.

Dr. Delacroix is in network with 18 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.